News
Stay Informed with the latest
Discover the latest news and press releases from our company.
All News
In the News
Press Releases
News
The 20(+2) under 40: Your guide to the next generation of biotech leaders.
May 25, 2023
Read more
News
Venture’s “Rule of Five” and SyntheX’s $550 million collaboration with Bristol Myers-Squibb.
Oct 4, 2022
Read more
News
Bristol Myers inks protein degrader deal via Celgene team’s link to seed-stage biotech.
Oct 4, 2022
Read more
News
‘There are no rules’: BMS enters lawless land of molecular degraders with $550M SyntheX deal.
Oct 4, 2022
Read more
Press Releases
SyntheX and Bristol Myers Squibb Enter Into a Research Collaboration to Discover and Develop Targeted Protein Degradation (TPD) Therapeutics.
Oct 4, 2022
Read more
Press Releases
MBC BioLabs Announces Recipients of the Golden Ticket Program. Press release PR newswire.
Jan 28, 2019
Read more
1
2
News
The 20(+2) under 40: Your guide to the next generation of biotech leaders.
May 25, 2023
Read more
News
Venture’s “Rule of Five” and SyntheX’s $550 million collaboration with Bristol Myers-Squibb.
Oct 4, 2022
Read more
News
Bristol Myers inks protein degrader deal via Celgene team’s link to seed-stage biotech.
Oct 4, 2022
Read more
News
‘There are no rules’: BMS enters lawless land of molecular degraders with $550M SyntheX deal.
Oct 4, 2022
Read more
Press Releases
SyntheX and Bristol Myers Squibb Enter Into a Research Collaboration to Discover and Develop Targeted Protein Degradation (TPD) Therapeutics.
Oct 4, 2022
Read more
Press Releases
MBC BioLabs Announces Recipients of the Golden Ticket Program. Press release PR newswire.
Jan 28, 2019
Read more